Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Short Term Second-Generation Antidepressant Monotherapy in Acute Depressive Episodes of Bipolar II Disorder: A Systematic Review and Meta-Analysis
1
x
$
30.00
C. Lindsay DeVane, PharmD: Clinical Significance of Drug Binding, Protein Binding, and Binding Displacement Drug Interactions
1
x
$
30.00
Jeffrey Alderman, PhD: The Effect of Food on the Absorption of Oral Ziprasidone
1
x
$
30.00
Demographic Variation in the Use of Prazosin for Treatment of Sleep Disturbance in Combat Veterans with PTSD
1
x
$
30.00
6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients
1
x
$
30.00
Struggling to find Effective Pharmacologic Options for Akathisia? B-CALM!
1
x
$
30.00
Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis
1
x
$
30.00
Mikael Landén, MD, PhD: Treatment Refractory Psychosis Remitted Upon Treatment with Continuous Positive Airway Pressure: A Case Report
1
x
$
30.00
A Pilot Study of the Pharmacodynamic Impact of SSRI Drug Selection and Beta-1 Receptor Genotype (ADRB1) on Cardiac Vital Signs in Depressed Patients: A Novel Pharmacogenetic Approach
1
x
$
30.00
Trichotieromania and Alopecia Areata Triggered by Aripiprazole- Methylphenidate Combo in an Autistic Child: The Nexus of Impulsivity-Compulsivity
1
x
$
30.00
Consistently Modest Antidepressant Effects in Clinical Trials: the Role of Regulatory Requirements (OPEN ACCESS)
2
x
$
0.00
Low-Dose Risperidone for an Autistic Child with Comorbid ARFID and Misophonia
1
x
$
30.00
The Ham-D is not Hamilton’s Depression Scale + Commentary on the Hamilton Rating Scale for Depression by Leon I. Rosenberg & Michael E. Thase
1
x
$
30.00
Remission as the Critical Outcome of Depression Treatment
1
x
$
30.00
Kenneth R. Gersing, MD: Practical Evidence-Based Medicine
1
x
$
30.00
Top-Up Clozapine for Risperidone LAI-Related Acute Dystonia and TR Bipolar in an Adolescent with ID-Putting the Cart before the Horse?
1
x
$
30.00
Vilazodone - Safety and Tolerability Profile PB VOL 44 No. 3
1
x
$
30.00
Carotid Artery Dissection Induced Acute Tongue Swelling in a Cocaine User (OPEN ACCESS)
1
x
$
0.00
Recent-Onset Schizophrenia and Adolescent Cannabis Use: MRI Evidence for Structural Hyperconnectivity?
1
x
$
30.00
A Case of Olanzapine-Induced Fever
1
x
$
30.00
Switching from Other Agents to Extended-Release Carbamazepine in Acute Mania
1
x
$
30.00
A Comprehensive Review of Lemborexant to Treat Insomnia
1
x
$
30.00
View Cart
Checkout
Home
Divalproex and Epilepsy
“A Comprehensive Review of Lemborexant to Treat Insomnia” has been added to your cart.
View cart
Divalproex and Epilepsy
$
30.00
Divalproex and Epilepsy
By L. James Willmore, MD
Divalproex and Epilepsy quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Category:
VOL 37 Supplement No. 2
Tags:
adverse-effects
,
divalproex
,
divalproex-and-epilepsy
,
efficacy
,
generalized-epiepsy
,
glutamate-transporters
,
l-james-willmore
,
mechanism-of-action
,
partial-epilepsy
,
valproate
,
valproic-acid
Description
Description
Divalproex and Epilepsy
By L. James Willmore, MD
4-PB_VOL-37-SUPPL-2
Related products
The History of Valproate in Clinical Neuroscience
$
30.00
Add to cart
Details
Efficacy and Tolerability of Controlled-Release Paroxetine
$
30.00
Add to cart
Details
Divalproex in the Treatment of Migraine
$
30.00
Add to cart
Details
Long-Term Treatment Strategies in Anxiety Disorders
$
30.00
Add to cart
Details
Page load link
Go to Top
